Medinet Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medinet Co., Ltd. with three other
companies in this sector in Japan:
Japan Tissue Engineering Company Limited
sales of 1.43 billion Japanese Yen [US$12.48 million]
of which 93%
was Regenerative Medicine Products Business),
PhoenixBio Co Ltd
(1.22 billion Japanese Yen [US$10.61 million]
Trans Genic Inc
(2.29 billion Japanese Yen [US$19.97 million]
of which 48%
was CRO Business).
Medinet Co., Ltd. reported sales of ¥1.91 billion (US$16.65 million)
September of 2016.
increase of 14.0%
versus 2015, when the company's sales were ¥1.67 billion.